Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. - Wikidata - wikimedia - TriplyDB

Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.

Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.

http://www.wikidata.org/entity/Q34571574

about

Carbapenemases: the versatile beta-lactamases Necrotizing fasciitis caused by Acinetobacter baumannii : A case report The growing burden of antimicrobial resistance.Multidrug resistant acinetobacter.In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters.Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug-resistant strains of Acinetobacter baumannii.ISAba825, a functional insertion sequence modulating genomic plasticity and bla(OXA-58) expression in Acinetobacter baumannii Drug treatment for multidrug-resistant Acinetobacter baumannii infections.Molecular epidemiology of imipenem-resistant Acinetobacter haemolyticus and Acinetobacter baumannii isolates carrying plasmid-mediated OXA-40 from a Portuguese hospital Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain Acinetobacter baumannii: emergence of a successful pathogen Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia Prevalence of Genes of OXA-23 Carbapenemase and AdeABC Efflux Pump Associated with Multidrug Resistance of Acinetobacter baumannii Isolates in the ICU of a Comprehensive Hospital of Northwestern China Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China.Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control Acinetobacter baumannii: An Emerging and Important Pathogen.A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital.Acinetobacter baumannii producing OXA-23 detected in the Czech Republic Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms.In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.The use of carbapenems in the treatment of serious infections.Diversity, epidemiology, and genetics of class D beta-lactamases Treatment of Acinetobacter infections.Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter.OXA β-lactamases.Genome sequence of OXA-23 producing Acinetobacter baumannii IHIT7853, a carbapenem-resistant strain from a cat belonging to international clone IC1.Antimicrobial Susceptibility and Clonal Relation Between Acinetobacter baumannii Strains at a Tertiary Care Center in Turkey.Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients.Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes.In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.Clinical and antimicrobial profile of Acinetobacter spp.: An emerging nosocomial superbug.Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in London.Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.

P2860

Q24685034-7B251EB8-8382-4A18-83B0-A7C01A6271EA Q28293095-033835F9-FC4B-461F-83B4-ACED8F41C1BC Q30371239-F950415E-8CC4-4007-8CA7-139C921E9983 Q33711902-EC3EE138-BE6E-4D42-ADA1-53CCC39CFFFC Q34134689-75EBE061-6DF1-4768-B207-AE5CC932A47B Q34163308-2205852C-5890-4F46-99D8-6D2CEBB2A954 Q34168334-B2D615C2-05FA-43FD-A89D-922A098B2E9E Q34309445-E63623AF-AF65-4C86-856C-5EBD2AB71668 Q34529149-03B909B0-F2CF-4203-A54B-56E2CD859F43 Q34601684-8CF91263-850A-4A95-A89E-E70545CE9C45 Q34644948-002A36DA-E568-471C-9EB2-53780C9C3403 Q34735979-585BC794-2648-4AA9-A6CE-5ADD23475CF8 Q34740954-9D82010F-7070-43D2-8166-73DB30B39DF2 Q34795807-694EA6D3-813C-4FBB-AA2A-5C5536BD225D Q35230346-8A203A89-E233-48D0-A02C-372D10ECB886 Q35986100-2F542E04-CA62-458A-9E1C-C48223504087 Q36013058-1FBC6EDC-7CFF-4E62-BB88-A47B19B71037 Q36178130-CD27AF72-C325-4BED-85B7-498732451F6E Q36314596-90BA43FE-E31F-483C-B9A8-3231E39D44B7 Q36638145-3482BE26-9AEC-4DF1-B09D-8330F4EE7F05 Q36664292-28EB582C-1FC1-44A1-89B5-04EE766F03DF Q36949527-282935EB-D31B-4977-B2FD-3DD7868C9286 Q37025416-249A00CD-0192-4591-A928-1FC673BF9EFD Q37058361-FD8947AD-34CF-4749-B11D-A6B0432706B0 Q37220041-A398D674-40D3-4954-B41F-869D304ABCB1 Q37555757-51182445-F0DD-4AD2-98DF-9C74556BE2EF Q37590023-6C244B35-9A7B-4E7C-90D9-CFB3845274C7 Q37704397-7AA89885-DABC-4725-AE45-A307723AF1FD Q37780543-117278C0-1F8E-4000-AE50-C43F2DDBCB39 Q38086337-9ED7D895-D2C5-4C07-9B58-1E0CAA10A10E Q38201699-30A27D67-40F1-47A3-9BBC-D243796701AB Q38836528-D15F2658-0AEA-4588-84F8-23BC79C912B4 Q41368137-CAD47F7E-9EFD-4214-9753-1EAC3CEF655C Q41763114-811E4AA1-9304-4A5B-A09B-121F7B3889E9 Q41789812-B335EC42-7D2A-4A5E-B9DA-74873F3248F3 Q41841445-1198A643-DE1B-47A4-9C54-868947FFFDB7 Q41861884-6316EE08-213E-4027-A0E0-0896240A3AF3 Q41965518-1E64F534-93D8-431A-8722-2EB33386B6C9 Q41988963-18629883-0E63-4562-BBF5-2C28FAE74001 Q41998459-F8DFB62A-C70B-4F65-A45E-83EF742C436C

P2860

Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.

http://www.wikidata.org/entity/Q34571574

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Occurrence of carbapenem-resis ...... London and Southeast England.

@ast

Occurrence of carbapenem-resis ...... London and Southeast England.

@en

Occurrence of carbapenem-resis ...... London and Southeast England.

@nl

type

label

Occurrence of carbapenem-resis ...... London and Southeast England.

@ast

Occurrence of carbapenem-resis ...... London and Southeast England.

@en

Occurrence of carbapenem-resis ...... London and Southeast England.

@nl

prefLabel

Occurrence of carbapenem-resis ...... London and Southeast England.

@ast

Occurrence of carbapenem-resis ...... London and Southeast England.

@en

Occurrence of carbapenem-resis ...... London and Southeast England.

@nl

P1433

Q34571574-3C793359-1BD2-4BA1-8729-B9792EC611A7

P1476

Q34571574-B40E9F2F-ED03-493E-9A25-DD4E72427FEA

P2093

Q34571574-2FB0EB21-0BD4-46E0-A718-8162C8D45CD2

Q34571574-316EE0F2-0093-425D-B7C4-5E791F55E936

Q34571574-510D2BED-A0C8-45DC-BFB5-5D7CEEAB485A

Q34571574-5B067921-3028-4A34-B2C7-4A6ED84A4A08

Q34571574-5EE4D709-1F4D-4AEE-AD1F-B9AA55D8A10D

Q34571574-883F983C-4AFD-49ED-87BA-C48BFD8E2428

Q34571574-8EF21961-5E0F-440D-A7BB-2EEF48C71FAC

Q34571574-AB64027B-6457-4EEC-BCDE-B22E9E1901E5

Q34571574-B49425D3-A794-44EE-A841-077F64AE4428

Q34571574-FBA44FC4-CCC8-408F-8AB8-ED267644FC06

P2860

Q34571574-0D95F119-E5A5-4D2A-8D2A-6F6CAB8C4751

Q34571574-11B5B82C-2997-42E0-9624-1C4FFADD7578

Q34571574-17CA960F-3ACB-4364-9A56-ACC0D90C0CC4

Q34571574-2D827D81-BC01-4F2A-921F-2A09C0FA51FD

Q34571574-34AA3FC1-67F8-4493-860A-CD9B0636ACD4

Q34571574-444F40C4-E751-42FA-9177-0C285C9CB04D

Q34571574-4D46D076-E55A-4945-9C8C-6866CBD51BA1

Q34571574-4F9806BB-24FC-45DA-96AC-4F06F852D943

Q34571574-5608DF9D-64DE-48B6-ACFF-ED10DFC3D77A

Q34571574-5E20F6A6-687B-4B12-A509-CB1B167F39CA

P304

Q34571574-1CA7A733-8280-4B64-A793-6ABABD907E15

P31

Q34571574-B292554C-CE45-4037-BBF1-D59303AB5C22

P356

Q34571574-E6CCE7F8-9B3D-4C70-BDE9-77E43BADAF35

P407

Q34571574-5D1A72B0-C5A3-4BC1-9E15-A261A037D801

P433

Q34571574-3A0CC18A-CC63-4AC8-9867-F26C55D94726

P478

Q34571574-852EB0CD-4BA9-4001-A7CC-75974AD7F41E

P50

Q34571574-8769F9D2-CC36-4A0D-A9D4-ABA8E7B28913

P577

Q34571574-98EC221F-A512-4D61-8C4D-265DA533C527

P5875

Q34571574-4CC07BCF-6701-4AB2-870C-06A3786D7D14

P698

Q34571574-72D5011E-1ACA-472F-83E7-E9165EA036D3

P921

Q34571574-02469E9B-87C2-48CE-BDD9-7371F193FF54

Q34571574-9D53B4B3-DD0B-4568-BDE7-DE6005F8FA95

P932

Q34571574-F73386BC-C4DB-456D-82F9-777A1EA088BF

P356

P1433

Journal of Clinical Microbiology

P1476

Occurrence of carbapenem-resis ...... London and Southeast England.

@en

P2093

Bharat C Patel

http://www.w3.org/2001/XMLSchema#string

David M Livermore

http://www.w3.org/2001/XMLSchema#string

Jane F Turton

http://www.w3.org/2001/XMLSchema#string

Judith Glover

http://www.w3.org/2001/XMLSchema#string

Juliana M Coelho

http://www.w3.org/2001/XMLSchema#string

Marie-France Palepou

http://www.w3.org/2001/XMLSchema#string

Marina Warner

http://www.w3.org/2001/XMLSchema#string

Mary E Kaufmann

http://www.w3.org/2001/XMLSchema#string

Rachel Pike

http://www.w3.org/2001/XMLSchema#string

Tyrone L Pitt

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

Tigecycline: what is it, and where should it be used?

Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii

Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii.

Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem.

Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Multiresistant acinetobacter in the UK: how big a threat?

P304

3623-3627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00699-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6774141

http://www.w3.org/2001/XMLSchema#string

P698

17021090

http://www.w3.org/2001/XMLSchema#string

P921

Acinetobacter baumannii

carbapenem antibiotic

P932

1594798

http://www.w3.org/2001/XMLSchema#string